Blood rheology is one of the determinants of perfusion and might therefore have an impact on the thromboembolic complications oflupus erythematosus. This study aimed at defining the flow properties of blood in patients with various types of lupus erythematosus. Results for 51 patients were compared with those for 20 controls matched for sex. The patients were divided into subgroups-chronic discoid, subacute cutaneous, and systemic lupus erythematosus-according to their clinical or laboratory characteristics. Blood and plasma viscosity, packed cell volume, red cell aggregation, and red cell deformability were used as parameters of blood rheology. Blood and plasma viscosity and red cell aggregation were significantly different in patients compared with controls, indicating reduced blood fluidity in lupus erythematosus. There were no marked sex differences. The rheological effects were greater in those with systemic lupus erythematosus than in those with chronic discoid or subacute cutaneous lupus erythematosus. The presence of a positive antinuclear antibody titre or methods of treatment (systemic steroids or retinoids) had no apparent effect on the parameters tested. It is suggested that a complex haemorheological deficit exists in lupus patients. 
Haemorheological abnormalities have been described in a number of autoimmune diseases.' These may be a mere epiphenomenon,2 but might also indicate an ability to hinder microcirculatory blood flow.3 In patients with lupus erythematosus blood rheology is known to be disturbed,4 but there have been no comprehensive studies on large, well defined groups. This study aimed at providing a detailed analysis of blood rheology in various clinical subsets of lupus erythematosus.
Patients and methods
Fifty one consecutive patients with confirmed diagnosis attending the lupus erythematosus clinic in the department of dermatology of Ludwig Maximilian University, Munich, were included in the study. Table 
Results
Values of all rheological variables were significantly higher in patients than in controls. The only exceptions were packed cell volume and shear standardised blood viscosity differed significantly (5-5 (0-13) v 5-01 (0-09) mPa.s in subacute cutaneous lupus erythematosus). By contrast, patients with systemic lupus erythematosus and chronic discoid lupus erythematosus showed significant differences in both standardised blood viscosities, packed cell volume, and red cell deformability (table 3) . Thirty eight of the 51 patients were antinuclear antibody positive. These patients showed no significant (or large numerical) differences in any of the tested variables when compared with the total group.
Patients with Raynaud's symptoms were found to have a significantly lower packed cell volume than those without (0 40 (0-01) v 0-44 (0 06)). Of the 11 patients with Raynaud's symptoms, five had systemic lupus erythematosus, three subacute cutaneous lupus erythematosus, and three chronic discoid lupus erythematosus.
Patients receiving oral steroids (13) 16 The increase in this parameter is thus explained by the above abnormalities in plasma proteins.
The reason for the limitation in red cell deformability, however, is unclear at present. One possibility is that this abnormality is related to a deficit in intraerythrocytic antioxidant enzymes, as reported in rheumatoid arthritis. 17 Clearly, the phenomenon of reduced red cell deformability in lupus erythematosus deserves more detailed study.
It is noteworthy that subsets of lupus erythematosus with a fairly good prognosis'8 are associated with relatively less haemorheological changes (table 3) . The 10 year survival rate of systemic lupus erythematosus, the group with the strongest rheological abnormalities, is only around 70%. 19 Patients with systemic lupus erythematosus have a high incidence of arterial occlusive disease, and various mechanisms might be considered. Possibly, future investigation could test whether the haemorheological deficit and the thromboembolic tendency are linked. Similar haemorheological changes are found in rheumatoid arthritis20 and ankylosing spondylitis. 3 The pathophysiological meaning of rheological abnormalities in rheumatic illness is as yet unclear.
